Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis

Exclusion Criteria

• •Subject has a clinically significant abnormality on physical exam, vital signs or ECG at the Week 4 visit of DRM04-HH04 or DRM04-HH05 study that would make further treatment with glycopyrronium contraindicated
• •Male with a history of urinary retention requiring catheterization due to prostatic hypertrophy or severe obstructive symptoms of prostatic hypertrophy
• •Any other condition which, in the judgement of the Investigator, would put the subject at unacceptable risk for participation in the study